| The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria P Hillmen, NS Young, J Schubert, RA Brodsky, G Socié, P Muus, A Röth, ... New England Journal of Medicine 355 (12), 1233-1243, 2006 | 1490 | 2006 |
| SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies M Hoffmann, P Arora, R Groß, A Seidel, BF Hörnich, AS Hahn, N Krüger, ... Cell 184 (9), 2384-2393. e12, 2021 | 994 | 2021 |
| Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria P Hillmen, P Muus, U Dührsen, AM Risitano, J Schubert, L Luzzatto, ... Blood, The Journal of the American Society of Hematology 110 (12), 4123-4128, 2007 | 745 | 2007 |
| Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria RA Brodsky, NS Young, E Antonioli, AM Risitano, H Schrezenmeier, ... Blood, The Journal of the American Society of Hematology 111 (4), 1840-1847, 2008 | 733 | 2008 |
| T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. B Fleischer, H Schrezenmeier The Journal of experimental medicine 167 (5), 1697-1707, 1988 | 591 | 1988 |
| Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men E Späth-Schwalbe, K Hansen, F Schmidt, H Schrezenmeier, L Marshall, ... The Journal of Clinical Endocrinology & Metabolism 83 (5), 1573-1579, 1998 | 562 | 1998 |
| Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation MC Florian, K Dörr, A Niebel, D Daria, H Schrezenmeier, M Rojewski, ... Cell stem cell 10 (5), 520-530, 2012 | 552 | 2012 |
| Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine N Frickhofen, JP Kaltwasser, H Schrezenmeier, A Raghavachar, HG Vogt, ... New England Journal of Medicine 324 (19), 1297-1304, 1991 | 528 | 1991 |
| Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia N Frickhofen, H Heimpel, JP Kaltwasser, H Schrezenmeier Blood, The Journal of the American Society of Hematology 101 (4), 1236-1242, 2003 | 482 | 2003 |
| Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria P Hillmen, P Muus, A Röth, MO Elebute, AM Risitano, H Schrezenmeier, ... British journal of haematology 162 (1), 62-73, 2013 | 453 | 2013 |
| Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European … A Locasciulli, R Oneto, A Bacigalupo, G Socié, E Korthof, A Bekassy, ... Haematologica 92 (1), 11-18, 2007 | 421 | 2007 |
| Mesenchymal stem cells for clinical application L Sensebe, M Krampera, H Schrezenmeier, P Bourin, R Giordano Vox sanguinis 98 (2), 93-107, 2010 | 413 | 2010 |
| Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy-The European Group for Blood and Marrow Transplantation experience A Bacigalupo, R Brand, R Oneto, B Bruno, G Sodé, J Passweg, ... Seminars in hematology 37 (1), 69-80, 2000 | 396 | 2000 |
| A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage J Wang, Q Sun, Y Morita, H Jiang, A Groß, A Lechel, K Hildner, ... Cell 148 (5), 1001-1014, 2012 | 383 | 2012 |
| Interleukin 21–induced granzyme B–expressing B cells infiltrate tumors and regulate T cells S Lindner, K Dahlke, K Sontheimer, M Hagn, C Kaltenmeier, TFE Barth, ... Cancer research 73 (8), 2468-2479, 2013 | 381 | 2013 |
| Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells J Dausend, A Musyanovych, M Dass, P Walther, H Schrezenmeier, ... Macromolecular bioscience 8 (12), 1135-1143, 2008 | 373 | 2008 |
| Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired … H Schrezenmeier, JR Passweg, JCW Marsh, A Bacigalupo, CN Bredeson, ... Blood, The Journal of the American Society of Hematology 110 (4), 1397-1400, 2007 | 372 | 2007 |
| Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells MR Lorenz, V Holzapfel, A Musyanovych, K Nothelfer, P Walther, H Frank, ... Biomaterials 27 (14), 2820-2828, 2006 | 371 | 2006 |
| Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study JW Lee, F Sicre de Fontbrune, L Wong Lee Lee, V Pessoa, S Gualandro, ... Blood, The Journal of the American Society of Hematology 133 (6), 530-539, 2019 | 349 | 2019 |
| Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow … N Fekete, M Gadelorge, D Fürst, C Maurer, J Dausend, ... Cytotherapy, 2012 | 338 | 2012 |
